EFNB2 and neoplasm: Assuming a very low or absent EphrinB2 protein expression in A375 cells, we would have expected tumor growth suppression as a consequence of EphB4 overexpression, comparable to the effect observed for overexpression of sEphB4, a soluble form of the EphB4 receptor only sufficient to activate EphrinB2 reverse signaling [64].